12:00 AM
Mar 18, 2013
 |  BC Week In Review  |  Company News  |  Other News

Pfizer gastrointestinal news

Pfizer said the U.S. Patent and Trademark Office (PTO) reissued U.S. Patent No. RE44048 covering pain and autoimmune drug Celebrex celecoxib. The reissue extends the original May 30, 2014, expiration date to Dec. 2,...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >